Documents
Application Sponsors
ANDA 090648 | GLAND PHARMA LTD | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 2MG BASE/ML | 0 | ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2012-06-15 | |
LABELING; Labeling | SUPPL | 3 | AP | 2013-06-30 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2015-01-09 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2015-01-09 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2021-08-18 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2021-08-18 | STANDARD |
LABELING; Labeling | SUPPL | 14 | AP | 2022-03-11 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 3 | Null | 15 |
SUPPL | 4 | Null | 7 |
SUPPL | 6 | Null | 7 |
SUPPL | 8 | Null | 7 |
SUPPL | 13 | Null | 7 |
SUPPL | 14 | Null | 7 |
TE Codes
CDER Filings
GLAND PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 90648
[companyName] => GLAND PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"ONDANSETRON HYDROCHLORIDE","activeIngredients":"ONDANSETRON HYDROCHLORIDE","strength":"EQ 2MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ONDANSETRON HYDROCHLORIDE","submission":"ONDANSETRON HYDROCHLORIDE","actionType":"EQ 2MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)